Literature DB >> 19630745

Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Lisa R Norman1, Michael Basso, Anil Kumar, Robert Malow.   

Abstract

Neuropsychological dysfunction, ranging from mild cognitive symptoms to dementia has been a consistent part of the clinical picture of HIV/AIDS. However, advances in clinical management, particularly antiretroviral (ARV) treatment, have mitigated the neuropsychological effects of HIV and revised the pattern and nature of cognitive deficits, which are observed in HIV-infected individuals. The attendant improvements in mortality and morbidity have led to a need for programs and interventions that sustain healthy behavior and prevent a resurgence of HIV transmission risk. Psychiatric risk factors, particularly substance use, which often contribute to initial acquisition of HIV, still require attention. These risk factors may also exacerbate neuropsychological dysfunction and compromise adherence to prevention recommendations and treatment. Specifically, a more complete understanding of the effects of substance abuse on the progression of HIV related cognitive decline can inform evaluation and management of HIV seropositives with concurrent substance use disorders. This review provides an overview of the neuropsychology of HIV and substance abuse and the extant research that has examined the effects of both HIV disease and substance use on neuropsychological functioning and implications for treatment and future research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630745      PMCID: PMC6167747          DOI: 10.2174/1874473710902020143

Source DB:  PubMed          Journal:  Curr Drug Abuse Rev        ISSN: 1874-4737


  168 in total

1.  Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT.

Authors:  M Iyo; H Namba; M Yanagisawa; S Hirai; N Yui; S Fukui
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-07       Impact factor: 5.067

Review 2.  Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment.

Authors:  Michael Copenhaver; S Kelly Avants; Lara A Warburton; Arthur Margolin
Journal:  J Psychoactive Drugs       Date:  2003 Apr-Jun

3.  Reversibility of alcohol-induced immune depression.

Authors:  H Tønnesen; A H Kaiser; B B Nielsen; A E Pedersen
Journal:  Br J Addict       Date:  1992-07

4.  Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.

Authors:  J D Jentsch; L Dazzi; J P Chhatwal; C D Verrico; R H Roth
Journal:  Neurosci Lett       Date:  1998-12-24       Impact factor: 3.046

5.  Effects of immunosuppression and disease severity upon neuropsychological function in HIV infection.

Authors:  M R Basso; R A Bornstein
Journal:  J Clin Exp Neuropsychol       Date:  2000-02       Impact factor: 2.475

6.  Neuropsychiatric impairment in patients with AIDS.

Authors:  D R Rubinow; R T Joffe; P Brouwers; K Squillace; H C Lane; A F Mirsky
Journal:  Adv Biochem Psychopharmacol       Date:  1988

Review 7.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

8.  Prevalence of cognitive disorders differs as a function of age in HIV virus infection.

Authors:  James T Becker; Oscar L Lopez; Mary Amanda Dew; Howard J Aizenstein
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

Review 10.  Neurobiology of HIV, psychiatric and substance abuse comorbidity research: workshop report.

Authors:  Kathy L Kopnisky; Jing Bao; Yu Woody Lin
Journal:  Brain Behav Immun       Date:  2007-03-07       Impact factor: 7.217

View more
  26 in total

Review 1.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

Review 2.  Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Authors:  Christopher Kent Arnatt; Yan Zhang
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

3.  Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.

Authors:  Scot McIntosh; Tammy Sexton; Lindsey P Pattison; Steven R Childers; Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-10       Impact factor: 4.147

4.  An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy.

Authors:  Michael Copenhaver; Roman Shrestha; Jeffrey A Wickersham; Damian Weikum; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2016-01-13

5.  Baseline clinical characteristics, antiretroviral therapy use, and viral load suppression among HIV-positive young men of color who have sex with men.

Authors:  Lisa B Hightow-Weidman; Karen Jones; Gregory Phillips; Amy Wohl; Thomas P Giordano
Journal:  AIDS Patient Care STDS       Date:  2011-06-28       Impact factor: 5.078

6.  Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats.

Authors:  Narasimha M Midde; Adrian M Gomez; Steven B Harrod; Jun Zhu
Journal:  Pharmacol Biochem Behav       Date:  2011-03-21       Impact factor: 3.533

7.  Neuropsychiatric and socioeconomic status impact antiretroviral adherence and mortality in rural Zambia.

Authors:  Gretchen L Birbeck; Michelle P Kvalsund; Peter A Byers; Richard Bradbury; Charles Mang'ombe; Natalie Organek; Trevor Kaile; Alex M Sinyama; Sylvester S Sinyangwe; Kennedy Malama; Costantine Malama
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

8.  Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study.

Authors:  Martin McElhiney; Judith Rabkin; Wilfred Van Gorp; Richard Rabkin
Journal:  J Clin Exp Neuropsychol       Date:  2009-11-24       Impact factor: 2.475

Review 9.  Geriatric syndromes: How to treat.

Authors:  Matteo Cesari; Emanuele Marzetti; Marco Canevelli; Giovanni Guaraldi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

10.  Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program.

Authors: 
Journal:  Clin Infect Dis       Date:  2012-11-21       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.